Skip to main content

Gastrointestinal Manifestations of COVID-19

  • Chapter
  • First Online:
COVID-19 Critical and Intensive Care Medicine Essentials

Abstract

Gastrointestinal manifestations of SARS-CoV-2 are reported in 10–50% of patients, being diarrhea, nausea, vomiting, and abdominal pain the most frequent ones. Gastrointestinal manifestations could be present without respiratory symptoms, leading to delayed diagnosis. In addition, COVID-19 is commonly associated with hepatic dysfunction manifesting with elevation of hepatic enzymes and total bilirubin levels, observed in up to 50% of the COVID-19 patients. Other less common gastrointestinal manifestations include acute cholecystitis, pancreatitis, and oral lesions. Clinicians should be also aware that the gastrointestinal tract is also frequently involved in COVID-19-related complications. As a matter of fact, several studies reported ileus, intestinal ischemia, perforation, and gastrointestinal bleeding during the course of COVID-19 disease. Lastly, the inappropriate and excessive use of antibiotics has led to an increase in Clostridioides difficile infection with consequent prolonged hospitalization and higher mortality. Although, the exact pathogenesis of gastrointestinal involvement is not completed understood, four main mechanisms have been advocated: the direct angiotensin converting enzyme 2 mediated viral cytotoxicity, cytokine-induced inflammation, gut dysbiosis, and vascular abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017–32.

    Article  CAS  PubMed  Google Scholar 

  2. Han Cha M, Regueiro M, Sandhu DS, et al. Gastrointestinal and hepatic manifestations of COVID-19: a comprehensive review. World J Gastroenterol. 2020;26(19):2323–32.

    Article  CAS  Google Scholar 

  3. Cheung KS, Hung IFN, Chan PPY, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159(1):81–95.

    Article  CAS  PubMed  Google Scholar 

  4. Leal T, Costa E, Arroja B, et al. Gastrointestinal manifestations of COVID-19: results from a European Centre. Eur J Gastroenterol Hepatol. 2021;33(5):691–4.

    Article  CAS  PubMed  Google Scholar 

  5. Vena A, Giacobbe DR, Di Biagio A, et al. Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy. Clin Microbiol Infect. 2020;26(11):1537–154.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Nobel YR, Phipps M, Zucker J, et al. Gastrointestinal symptoms and COVID-19: case–control study from the United States. Gastroenterology. 2020;159:373–5.

    Article  CAS  PubMed  Google Scholar 

  7. Redd WD, Zhou JC, Hathorn KE, et al. Prevalence and characteristics of gastrointestinal symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection in the United States: a multicenter cohort study. Gastroenterology. 2020;159:765–7.

    Article  CAS  PubMed  Google Scholar 

  8. Mao R, Qiu Y, He J-S, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667–78.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sultan S, Altayar O, Siddique SM, et al. AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020;159(1):320–34.

    Article  CAS  PubMed  Google Scholar 

  10. Buscarini E, Manfredi G, Brambilla G, et al. GI symptoms as early signs of COVID-19 in hospitalised Italian patients. Gut. 2020;69(8):1547–8.

    Article  PubMed  CAS  Google Scholar 

  11. Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res. 2020;30:367–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Devaux CA, Lagier J, Raoult D. New insights into the physiopathology of COVID-19: SARS-CoV-2 associated gastrointestinal illness. Front Med (Lausanne). 2021;8:640073.

    Article  Google Scholar 

  13. Xiao F, Tang M, Zheung X, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–3.

    Article  CAS  PubMed  Google Scholar 

  14. Parasa S, Desai M, Chandrasekar VT, et al. Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(6):e2011335.

    Article  PubMed  PubMed Central  Google Scholar 

  15. D'Amico F, Baumgart DC, Danese S, et al. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol. 2020;18(8):1663–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zuo T, Zhang F, Lui GC, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944–55.

    Article  CAS  PubMed  Google Scholar 

  17. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis and angiogenesis in COVID-19. N Engl J Med. 2020;383:120–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Kim KD, Zhao J, Auh S, et al. Adaptive immune cells temper initial innate responses. Nat Med. 2007;13(10):1248–52.

    Article  CAS  PubMed  Google Scholar 

  20. Huang KJ, Su IJ, Theron M, et al. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol. 2005;75(2):185–94.

    Article  CAS  PubMed  Google Scholar 

  21. Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Fang D, Ma J, Guan J, et al. Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study. Chin J Dig. 2020;12:E005.

    Google Scholar 

  24. Rowley AH. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat Rev Immunol. 2020;20(8):453–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Mutiawati E, Fahriani M, Mamada SS, et al. Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms—a systematic review and meta-analysis. F1000Res. 2021;10:40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Xu L, Liu J, Lu M, et al. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40(5):998–1004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428–30.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Hajifathalian K, Krisko T, Mehta A, et al. Gastrointestinal and hepatic manifestations of 2019 novel coronavirus disease in a large cohort of infected patients from New York: clinical implications. Gastroenterology. 2020;159(3):1137–40.

    Article  CAS  PubMed  Google Scholar 

  29. Taramasso L, Vena A, Bovis F, et al. Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations. Microorganisms. 2020;8(12):2010.

    Article  PubMed Central  Google Scholar 

  30. Bangash MN. COVID-19 and the liver: little cause concern. Lancet Gastroenterol Hepatol. 2020;5:529–30.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Li J, Fan JG. Characteristics and mechanism of liver injury in 2019 coronavirus disease. J Clin Transl Hepatol. 2020;8(1):13–7.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Sun JK, Liu Y, Zou L, et al. Acute gastrointestinal injury in critically ill patients with COVID-19 in Wuhan, China. World J Gastroenterol. 2020;26(39):6087–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Scutari R, Piermatteo L, Ciancio Manuelli M, et al. Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids including bile in two patients with acute cholecystitis. Life (Basel). 2020;10(11):302.

    CAS  Google Scholar 

  34. Mattone E, Sofia M, Schembari E, et al. Acute acalculous cholecystitis on a COVID-19 patient: a case report. Ann Med Surg (Lond). 2020;58:73–5.

    Article  CAS  Google Scholar 

  35. McNabb-Baltar J, Jin DX, Grover AS, et al. Lipase elevation in patients with COVID-19. Am J Gastroenterol. 2020;115(8):1286–8.

    Article  PubMed  Google Scholar 

  36. Farid H, Khan M, Jamal S, et al. Oral manifestations of Covid-19—a literature review. Rev Med Virol. 2021;32:e2248.

    PubMed  PubMed Central  Google Scholar 

  37. Brandão TB, Gueiros LA, Melo TS, et al. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131(2):e45–51.

    Article  PubMed  Google Scholar 

  38. El Moheb M, Naar L, Christensen MA, et al. Gastrointestinal complications in critically ill patients with and without COVID-19. JAMA. 2020;324(18):1899–901.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Parry AH, Wani AH, Yaseen M. Acute mesenteric ischemia in severe Coronavirus-19 (COVID-19): possible mechanisms and diagnostic pathway. Acad Radiol. 2020;27(8):1190.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Kaafarani HMA, El Moheb M, Hwabejire JO, et al. Gastrointestinal complications in critically ill patients with COVID-19. Ann Surg. 2020;272(2):e61–2.

    Article  PubMed  Google Scholar 

  41. Gartland RM, Velmahos GC. Bowel necrosis in the setting of COVID-19. J Gastrointest Surg. 2020;24(12):2888–9.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Kerawala AA, Das B, Solangi A. Mesenteric ischemia in COVID-19 patients: a review of current literature. World J Clin Cases. 2021;9(18):4700–8.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Vikse J, Henry BM. Tocilizumab in COVID-19: beware the risk of intestinal perforation. Int J Antimicrob Agents. 2020;56(1):106009.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Martin TA, Wan DW, Hajifathalian K, et al. Gastrointestinal bleeding in patients with coronavirus disease 2019: a matched case-control study. Am J Gastroenterol. 2020;115(10):1609–16.

    Article  PubMed  Google Scholar 

  45. Rawson TM, Moore LS, Castro-Sánchez E, et al. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020;75:1681–4.

    Article  CAS  PubMed  Google Scholar 

  46. Magnasco L, Mikulska M, Giacobbe DR, et al. Spread of carbapenem-resistant Gram-Negatives and Candida auris during the COVID-19 pandemic in critically ill patients: one step back in antimicrobial stewardship? Microorganisms. 2021;9(1):95.

    Article  CAS  PubMed Central  Google Scholar 

  47. Khanna S, Kraft CS. The interplay of SARS-CoV-2 and Clostridioides difficile infection. Future Microbiol. 2021;16:439–43. https://doi.org/10.2217/fmb-2020-0275.

    Article  CAS  PubMed  Google Scholar 

  48. Puoti MG, Rybak A, Kiparissi F, et al. SARS-CoV-2 and the gastrointestinal tract in children. Front Pediatr. 2021;9:617980.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Sahn B, Eze OP, Edelman MC, et al. Features of intestinal disease associated with COVID-related multisystem inflammatory syndrome in children. J Pediatr Gastroenterol Nutr. 2021;72(3):384–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matteo Bassetti .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bassetti, M., Vena, A., Giacobbe, D.R., Briano, F., Portunato, F. (2022). Gastrointestinal Manifestations of COVID-19. In: Battaglini, D., Pelosi, P. (eds) COVID-19 Critical and Intensive Care Medicine Essentials. Springer, Cham. https://doi.org/10.1007/978-3-030-94992-1_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-94992-1_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-94991-4

  • Online ISBN: 978-3-030-94992-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics